Illuminating the Path to Cure

Join our global network of cancer focused professionals

Illuminating the Path to Cure

Join our global network of cancer focused professionals

A transformative experience

Provides the continuum of exploration, relationship building, project creation and management in a secure cloud-based environment

Fundamentally redefine how you collaborate.

    Search for relevant global expertise, information and resources.

    Create personnel directories within and across organizations.

    Manage a complex interplay of relationships between cross-disciplinary :

  • Departments/divisions
  • Other cancer focused organization

    Streamline communication between all parties using our real-time
    monitoring and tiered role-based privacy solution.

    Access documents, information and third-party tools through a common     dashboard.

Who should register ?

Oncology professionals engaged in the following activities:

  • Allied professionals
  • Clinical research
  • Government
  • Regulation
  • Advocacy
  • Commercialization
  • Manufactoring
  • Translational research
  • Basic science
  • Financing
  • Patient care

Why use Lumiseek?

Successful execution of research, clinical trials and commercialization projects is contingent upon the effective management of :

  • A complex array of interdisciplinary relationships across multiple departments, organizations and locations
  • Nuanced resources and logistics
  • Interactions that need to be coordinated in real-time

The resulting inefficiency and redundancy collectively amounts to billions of dollars in lost value.

Lumiseek is the only comprehensive platform that effectively streamlines these activities.

Value Potential

Reduce your project
costs

Expand your market
and customers

Get to market sooner

Increase your
productivity

Awards

Testimonials

Dr. Balaji Bhayravbhatla

Managing Director, Hylasco

”You have utilized your deep domain expretise very well to design a solution for the whole oncology industry. I am excited to be a part of this platform and look forward to using the multiple integrated functions.”

home tab-UNmesh-Lal-150x150-1

Mr. Unmesh Lal

Program Manager – Life Sciences, Transformational health, Frost & Sullivan

”Lumiseek provides an exceptional value proposition to all stakeholders: drug development companies, hospitals, contract research organizations, and regulatory bodies. The company’s platform synchronizes communication and project management workflow for high-level networking throughout the discovery, development, clinical trials, and commercialization of oncology therapeutics and diagnostics.”

2.Sam Mbulaiteye

Dr. Sam Mbulaiteye

Senior Investigator, Division of Cancer Epidemiology & Genetics, National Cancer Institute

“Lumiseek platform is an excellent model for doing two things- one to bring all the intellectuals together and initiate collaboration and immediately brings the government to provide funding or regulatory easing.”

Dr. Balaji Bhayravbhatla

Managing Director, Hylasco

”You have utilized your deep domain expretise very well to design a solution for the whole oncology industry. I am excited to be a part of this platform and look forward to using the multiple integrated functions.”

home tab-UNmesh-Lal-150x150-1

Mr. Unmesh Lal

Program Manager – Life Sciences, Transformational health, Frost & Sullivan

”Lumiseek provides an exceptional value proposition to all stakeholders: drug development companies, hospitals, contract research organizations, and regulatory bodies. The company’s platform synchronizes communication and project management workflow for high-level networking throughout the discovery, development, clinical trials, and commercialization of oncology therapeutics and diagnostics.”

2.Sam Mbulaiteye

Dr. Sam Mbulaiteye

Senior Investigator, Division of Cancer Epidemiology & Genetics, National Cancer Institute

“Lumiseek platform is an excellent model for doing two things- one to bring all the intellectuals together and initiate collaboration and immediately brings the government to provide funding or regulatory easing.”